$CPHI News

China Pharma Holding Q1 EPS $(0.04) Up From $(0.24) YoY, Sales $983.536K Down From $1.136M YoY

China Pharma Holding Q4 EPS $(0.17) Up From $(0.40) YoY, Sales $1.226M Up From $1.134M YoY

Hainan Helpson Medical & Biotechnology Strikes Deal With Xiaoyun Chen To Acquire Invention Patent Of An Topiroxostat Nanoemulsion And Method for Its Preparation For $8.82M

China Pharma Subsidiary Helpson Acquires Ipragliflozin Patent For $9.8M Paid In Common Stock At $1.40/Share

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Intraday Session

Crude Oil Down 2%; Chanson International Shares Spike Higher

US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern

Levi Strauss, Dave & Buster's Entertainment And 3 Stocks To Watch Heading Into Monday

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

12 Health Care Stocks Moving In Friday's After-Market Session

China Pharma Holdings To Implement 1-For-10 Reverse Stock Split, Effective April 15, 2025

China Pharma Holdings To Implement 1-For-10 Reverse Stock Split, Effective April 15, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

China Pharma Announces the Entry of "At-The-Market" Equity Offering

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

China Pharma expects to launch dry eye disease therapeutic device in Q1

China Pharma subsidiary plans to launch dry eye treatment in Q1 of 2025 in China

CPHI Stock Earnings: China Pharma Holding Reported Results for Q2 2024